Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC11206304 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature